Lingran Du
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
- Co-authors
- Jijun Fu (11 shared papers)Yi Zhou (7 shared papers)Xiyong Yu (7 shared papers)Yugang Huang (11 shared papers)He Wang (4 shared papers)Minyan Wei (4 shared papers)Liang Gu (1 shared paper)Jiayi Guo (1 shared paper)
- Journals
- International Journal of Pharmaceutics (3 papers)Acta Pharmaceutica Sinica B (2 papers)International Journal of Biological Macromolecules (2 papers)Journal of Nanobiotechnology (2 papers)Materials Science and Engineering C (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Lingran Du
21 papers receiving 473 citations
Peers
Comparison fields: 5 of 80
- Pharmaceutical Science 75
- Biomaterials 110
- Molecular Medicine 19
- Cancer Research 51
- Biomedical Engineering 143
Countries citing papers authored by Lingran Du
This map shows the geographic impact of Lingran Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingran Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingran Du more than expected).
Fields of papers citing papers by Lingran Du
This network shows the impact of papers produced by Lingran Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingran Du. The network helps show where Lingran Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingran Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 97 | |
| 2 | 2019 | 64 | |
| 3 | 2020 | 53 | |
| 4 | 2015 | 50 | |
| 5 | 2014 | 42 | |
| 6 | 2018 | 39 | |
| 7 | 2007 | 27 | |
| 8 | 2019 | 26 | |
| 9 | 2014 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2013 | 8 | |
| 14 | 2020 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2024 | 1 |
About Lingran Du
Lingran Du is a scholar working on Biomaterials, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging, having authored 23 papers that have together received 478 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced Drug Delivery Systems (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Nanoplatforms for cancer theranostics (2 papers), Intracranial Aneurysms: Treatment and Complications (2 papers), Advancements in Transdermal Drug Delivery (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Pharmaceutical Science (75 citations), Biomaterials (110 citations), Molecular Medicine (19 citations), Cancer Research (51 citations) and Biomedical Engineering (143 citations). Lingran Du has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Jijun Fu, Yi Zhou, Xiyong Yu, Yugang Huang, He Wang, Minyan Wei, Liang Gu, Jiayi Guo, Xiaoqin Zhou and Mingna Sun. Their work appears in journals such as International Journal of Pharmaceutics, Acta Pharmaceutica Sinica B, International Journal of Biological Macromolecules, Journal of Nanobiotechnology and Materials Science and Engineering C.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.